Letter From The Editor

When George McConnell, PharmD. Candidate, LECOM School of Pharmacy, was in our rotation, he had to review patients using CGM devices to manage their diabetes. He learned very quickly how patients could take advantage of the devices to improve their Time In Range (TIR). This is very quickly becoming the …

In our last newsletter, we discussed the burden that new technology can have on children, and how the extra stress of having information at our fingertips can be overwhelming. This week, our intern from LECOM College of Pharmacy, Tarshay Boyd, takes a look at how coupling these devices with Telehealth …

As the spouse of an adult who has type 1 diabetes, I know the value of using a CGM. Just using the device gives her a sense of security and has increased her TIR immensely. However, with this technology there is an increased sense of responsibility, and there is never …

This week we offer you part 3 of our series on the use of AI to select a proper diabetes medication regimen. Your response to the information has been overwhelming, and if the comments we have received are an indication of the desire to have this tool available, it only …

When Steve and I first started Diabetes in Control we tried to attend every conference and speak to every thought leader we could find. Back then pharmacists did not garner a lot of respect from endocrinologists, and often we were blown off for every interview. There were a few who …

If you pick up any technology related medical journal or magazine, you can’t go more than a dozen pages before you find the first article or study about the use of AI (artificial intelligence). It seems that almost every medical specialty is taking advantage of the billions of split second …

A lot of people have stayed away from gyms over the past 6 months, and many have had to adapt their exercise regimens. Some of our patients are now returning to the gym and are wanting to build back the muscle they have lost. Too many times, patients will think …

When we add medications for our patients, our focus is usually directed by such things as A1C, Time in Range, maximum highs and the like. However, when we add these medications we don’t see a noticeable difference in the aforementioned parameters. A good example of how adding medications that don’t …

For years a high body mass index or obesity has been associated with pancreatic cancer, and diabetes has also been seen as an indicator of a greater propensity for developing pancreatic cancer. With these two factors in mind, common logic would say that if your diabetes patient loses weight their …

For the past 6 months, we have heard how patients with diabetes have an increased risk of getting COVID-19, and how the symptoms will be much worse, and diabetes patients are at increased risk for death, from COVID-19 complications. Now there are a group of medical professionals who feel that …